Leukemia, Myelodysplasia, Transplantation
From the Journals
Patients with lung and blood cancers most vulnerable to COVID-19
From the Journals
Extended virus shedding after COVID-19 in some patients with cancer
Some patients, including stem cell transplant and CAR T recipients, may require extended periods of isolation.
Conference Coverage
Black race linked to poorer survival in AML
Conference Coverage
Fixed duration ibrutinib/venetoclax appears feasible for some CLL/SLL patients
Conference Coverage
In MDS, transplant ups survival in elderly and may be reimbursed
From the Journals
Cancer rates on the rise in adolescents and young adults
Conference Coverage
Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest
Cancer patients treated with immune checkpoint inhibitors are not significantly more likely to develop or die from COVID-19, two studies suggest...
From the Journals
Pigment traits, sun sensitivity associated with risk of non-Hodgkin lymphomas and chronic lymphocytic leukemia
The presence of “many or very many nevi [moles]” was particularly associated with the risk of CLL.
From the Journals
‘Impressive’ outcomes sans chemo in poor-prognosis ALL
Conference Coverage
Immunotherapy for ALL: Roles emerge in R/R disease, MRD+ disease
“Another very exciting development is that these immunotherapies are now demonstrating efficacy and increased tolerability over chemotherapy in...
Clinical Insights
Using telehealth to deliver palliative care to cancer patients
Dr. Alan Lyss discusses the use of telehealth for palliative cancer care, including results from the REACH PC trial.